. Author manuscript; available in PMC: 2009 Jul 13.

Published in final edited form as: J Heart Lung Transplant. 2006 Apr 11;25(5):579–588. doi: 10.1016/j.healun.2006.01.006

Table 1.

Patient Characteristics

Parameter	Subj 1	Subj 2	Subj 3	Subj 4	Subj 5	Subj 6	Subj 7	Subj 8
Age	39	57	63	61	64	51	57	39
Sex/race	M/C	M/C	M/C	M/C	M/C	M/C	M/C	M/C
LVEF BSL→EOS	17→32	26→15	18→37	31→53	8→51	35→51	25→50	19→48
Chip scaling factor	High/high	Low/low	Low/low	Low/high	Low/low	Low/high	High/high	Low/low
Rx	Carv	Pbo	Met	Carv	Pbo	Met	Carv	Carv
Peak VO₂ (ml/kg/min)	20	19	18	15	N/A	14	16	20
NYHA	III	II	II	III	IV	III	II	III
Cl (l/min/m²)	2.2	2.5	1.2	2.9	2.4	1.8	1.4	2.9

BSL, baseline; EOS, end-of study; Pbo, placebo; Met, metoprolol; Carv, carvedilol; NYHA, New York Heart Association classification.